Patents Assigned to VasonGenix Pharmaceuticals, Inc.
  • CONTROLLED RELEASE CGRP DELIVERY COMPOSITION FOR CARDIOVASCULAR AND RENAL INDICATIONS
    Publication number: 20110244005
    Abstract: The present invention provides methods of treating heart failure and improving renal function, and/or preventing the advancement of heart failure into advanced stages, and methods of counteracting ischemia due to a myocardial infarction by providing improved methods of administering a therapeutically effective amount CGRP as a controlled release formulation. The therapies can be administered on an outpatient or inpatient basis and can further be used as maintenance therapies.
    Type: Application
    Filed: June 16, 2011
    Publication date: October 6, 2011
    Applicant: VasonGenix Pharmaceuticals, Inc.
    Inventors: Jeffrey L. Southard, George L. Southard